Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

5336 - Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC)

Date

20 Oct 2018

Session

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

Presenters

FEIYU ZHANG

Citation

Annals of Oncology (2018) 29 (suppl_8): viii649-viii669. 10.1093/annonc/mdy303

Authors

F. ZHANG1, N. Dong2, S. Torres1, S. Calabuig Fariñas3, R. Sirera Perez4, M. Mosqueda1, E. Escorihuela5, E. Jantus-Lewintre6, C. Camps7

Author affiliations

  • 1 Molecular Oncology, Fundación de Investigación Hospital General Universitario de Valencia, 46014 - Valencia/ES
  • 2 Molecular Oncology, Fundación de Investigación Hospital General Universitario de Valencia, 46014 - valencia/ES
  • 3 Molecular Oncology, Molecular Oncology Lab. Fundación Investigación Hospital General Universitario Valencia, Valencia, Spain; Centro Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain; Dep. of Pathology, Universitat de València, Valencia, Spain, 46018 - Valencia/ES
  • 4 Biotechnology Department, Universidad Politécnica de Valencia-CIBERONC, 46005 - Valencia/ES
  • 5 Molecular Oncology, Fundación de Investigación Hospital General Universitario de Valencia-CIBERONC, 46014 - valencia/ES
  • 6 Molecular Oncology Lab, Molecular Oncology Lab. Fundación Investigación Hospital General Universitario Valencia, Valencia, Spain; Centro Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain; Dep. of Biotechnology, Universitat Politècnica València, Valencia, Spain, 46014 - Valencia/ES
  • 7 Medical Oncology, Dep. of Medical Oncology, Hospital General Universitario de Valencia, Valencia, Spain; Centro Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain; Dep. of Medicine, Universitat de València, Valencia, Spain, 46014 - Valencia/ES
More

Resources

Abstract 5336

Background

Lung cancer stem cells (CSCs) are a small subpopulation of cells with self-renewal, tumorigenic properties and the ability to grow to form tumorspheres in non-adherent conditions. Recently, the study on soluble molecules has been a new focus to understand the interaction between CSCs and tumor microenvironment. The aim of this work is to compare the release of cytokines between monolayer cells and tumorspheres of NSCLC cultures.

Methods

The study was performed on medium supernatant of cells from 8 NSCLC tumour patients samples and 10 cell lines (A549, H1650, H460, H23, H358, H2228, HCC827, PC9, H1993, SW900) grown in monolayer and tumorspheres at 2 different densities (104 and 105 cells/ml); supernatant was recollected at 12h and 24h. We analyzed 8 soluble factors with immunosuppressive (IL-4, IL-10, IL-13), and immunoregulatory (IL-6, IL-8, IL-17A, TNFa, IFN) capacity through sensitivity bead-based multiplex assay using the Millipore kit from the Luminex 100/200.

Results

IL-4, IL-6, IL-8, TNFa levels were detected in all samples while IFN, IL-10, IL-13, IL-17A were beyond the detectable range in adherents for most of cultures (Detection range [pg/ml] of IL-4: 1.83-7497.38, IL-6: 0.18-813.66, IL-8: 0.31-1042.75, TNFa: 0.43-1758.47, IFN: 0.61-2468.39, IL-10: 1.46-6056.85, IL-13: 0.24-1002.76, IL-17A: 0.73-3074.88). We observed significant differences in levels of IL-6, IL-13, IL-17A, TNFa, IFN between adherent cells and tumorspheres. Moreover, IL-4, IL-10, IL-13, IL-17A, IFN levels in tumorspheres were higher than monolayer. Otherwise, IL-6 and TNFa were secreted more in monolayer. IL-8 is the most secreted molecule in both adherents and tumorspheres by all cultures.

Conclusions

Our preliminary results suggest that high levels of IL-6 and IL-8 were detected in all samples. IL-8, IL-13, IL-17A and IFN secreted by lung CSCs could be involved in the modulation of the immune microenvironment. Additionally, adherent cells show increased levels of IL-6 and TNFa compared to tumorspheres, and IL-8, IL-4, IFN, IL-10, IL-13, IL-17A show the opposite. The next is to extend the cohort to validate our results and to study others immunoregulatory factors. Supported by grants from FEDER and PI12-02838 and PI15-00753 from ISCIII.

Clinical trial identification

Legal entity responsible for the study

Fundación de Investigación del Hospital General Universitario de Valencia.

Funding

Supported by grants from FEDER and PI12-02838 and PI15-00753 from ISCIII.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings